CnT-Prime Basal Medium
a basal medium used in all the CnT-Prime range of media and containing a low calcium concentration specifically chosen for optimal long-term proliferation of epithelial progenitor cells.
|Content||500 ml, Frozen medium|
The CnT-PR-BM.1 basal medium is used in all the CnT-Prime range of media. It contains a full range of amino acids, vitamins, and minerals. It contains a low calcium concentration (0.07 mM), that is specifically chosen for optimal long-term proliferation of epithelial progenitor cells.
- Tissue type
- Epithelial cells
- Isolation / Expansion
- Free of Human & Animal Component
- Chemically defined
- Clinically upgradable
- 500 ml
- Frozen Bottle & Ready-to-use
- Quality level
- Research Grade
CnT-Prime Basal Medium is a fully defined, low calcium (0.07 mM) basal medium formulation designed for optimal isolation, growth, and longevity of primary epithelial cells. It is completely free of animal or human-derived components. CnT-Prime Basal Medium contains a full range of amino acids, minerals, vitamins and organic compounds. It does not contain growth factors, phenol-red, or antibiotics / antimycotics. Growth factors must be added to obtain cell proliferation.
CnT-Prime Basal Medium is the basal medium formulation used during preparation of the CnT-PR, CnT-PR-D, CnT-PR-3D, CnT-PR-CA, CnT-PR-A, and CnT-PR-AD media. It does not contain growth factors, and thus can be used when cells must be starved of stimulation for a defined period prior to experimentation. This medium is designed for use in a 5% CO2 atmosphere.
For routine cell cultivation, CELLnTEC does not recommend the use of antibiotics / antimycotics. During isolation, antibiotics / antimycotics are recommended up until the end of P1.
|A Three-Dimensional Organoid Culture Model to Assess the Influence of Chemicals on Morphogenetic Fusion||A Three-Dimensional Organoid Culture Model to Assess the Influence of Chemicals on Morphogenetic Fusion||2018||Epidermal|
|miR-24 controls the regenerative competence of hair follicle progenitors by targeting Plk3||Fengzhen Liu, Xia Zhang, You Peng, Liping Zhang, Yao Yu, Peng Hua, Peiying Zhu, Xinyu Yan, Yin Li, Liang Zhang||2021||Epidermal|
|Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma||Markus Eberl, Doris Mangelberger, Jacob B. Swanson, Monique E. Verhaegen, Paul W. Harms, Marcus L. Frohm, Andrzej A. Dlugosz, Sunny Y. Wong||2018||Epidermal|